These include numbness, tingling, or difficulty walking
doi:10.18632/aging.202829
The Plateau Problem - Why GLP-1 Therapies Stop Working (and What To Do About It) Share The Plateau Problem Why GLP-1 Therapies Stop Working (and What To Do About It) GLP-1 therapies like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have delivered remarkable results for many patientsbut for a growing number, theres a common frustration: It was working and then it wasnt. Weight loss slows
Gradual dose escalation can significantly mitigate the frequency and severity of symptoms such as nausea and diarrhea, as it allows patients to adapt to therapy over time ( It should be noted that this study did not conduct subgroup analyses based on dosage and administration routes, which may limit the comprehensive assessment of GLP-1RA safety
Ans: Yes, it is dermatologically tested
The risk is considered so low that routine thyroid ultrasound screening is not recommended for most patients starting these drugs
